These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2073095)

  • 1. Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers.
    Singh KV; Reves RR; Pickering LK; Murray BE
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2047-9. PubMed ID: 2073095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas.
    Reves RR; Fong M; Pickering LK; Bartlett A; Alvarez M; Murray BE
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1429-34. PubMed ID: 2201257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.
    Wu PJ; Shannon K; Phillips I
    Antimicrob Agents Chemother; 1994 Mar; 38(3):494-8. PubMed ID: 8203843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
    Diagn Microbiol Infect Dis; 1986 Jul; 5(2):151-62. PubMed ID: 3522088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
    Beskid G; Fallat V; Siebelist J; Durkin JW; Lipschitz ER; McGarry DH
    J Clin Microbiol; 1987 Jul; 25(7):1186-90. PubMed ID: 3112176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.
    Stapleton P; Wu PJ; King A; Shannon K; French G; Phillips I
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2478-83. PubMed ID: 8585729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
    Doern GV; Chapin KC
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1143-8. PubMed ID: 3190202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the in vitro activity of amoxicillin/clavulanic acid and other beta-lactam antibiotics against Escherichia coli isolated from urine specimens.
    Vanhoof R; Carpentier M; Delannoy P; Fagnart O; Lontie M; Mans I; Nyssen HJ; Van Nimmen L
    Acta Clin Belg; 2001; 56(1):32-7. PubMed ID: 11307481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.
    Reves RR; Murray BE; Pickering LK; Prado D; Maddock M; Bartlett AV
    J Infect Dis; 1987 Nov; 156(5):758-62. PubMed ID: 3309072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the sensitivity of Escherichia coli to 6 antimicrobial agents during the last 12 years. Group of Microbiologists of County Hospitals of Catalonia].
    Sauca G; Gallés C; Gasós MA
    Aten Primaria; 1997 Mar; 19(5):226-9. PubMed ID: 9264651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity to clavulanic acid of Escherichia coli isolated at the Henri Mondor hospital in 1986 according to phenotypes of beta-lactam antibiotic resistance].
    Soussy CJ; Le Van Thoi J; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):442-5. PubMed ID: 3043340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
    Bingen E; Bourgeois F; Chardon H; Doit C; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):923-6. PubMed ID: 1486888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
    Delmée M; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
    Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
    Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
    Barry AL; Fuchs PC; Pfaller MA
    Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2902-4. PubMed ID: 7695280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group.
    Chardon H; Farzaneh S; Labia R; Jarlier V; Nicolas MH; Paul G; Poyart C; Sirot D; Sirot J
    J Antimicrob Chemother; 1995 Jul; 36(1):267-9. PubMed ID: 8537279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.